- Home
- CCM vs KALA Comparison
CCM vs KALA Comparison
Compare CCM & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- KALA
- Stock Information
- Founded
- CCM 1997
- KALA 2009
- Country
- CCM China
- KALA United States
- Employees
- CCM N/A
- KALA N/A
- Industry
- CCM Medical/Nursing Services
- KALA Biotechnology: Pharmaceutical Preparations
- Sector
- CCM Health Care
- KALA Health Care
- Exchange
- CCM Nasdaq
- KALA Nasdaq
- Market Cap
- CCM 33.3M
- KALA 26.2M
- IPO Year
- CCM 2009
- KALA 2017
- Fundamental
- Price
- CCM $5.66
- KALA $5.16
- Analyst Decision
- CCM
- KALA Strong Buy
- Analyst Count
- CCM 0
- KALA 3
- Target Price
- CCM N/A
- KALA $14.00
- AVG Volume (30 Days)
- CCM 2.5K
- KALA 71.9K
- Earning Date
- CCM 04-25-2025
- KALA 08-05-2025
- Dividend Yield
- CCM N/A
- KALA N/A
- EPS Growth
- CCM N/A
- KALA N/A
- EPS
- CCM N/A
- KALA N/A
- Revenue
- CCM $52,603,198.00
- KALA N/A
- Revenue This Year
- CCM N/A
- KALA N/A
- Revenue Next Year
- CCM N/A
- KALA N/A
- P/E Ratio
- CCM N/A
- KALA N/A
- Revenue Growth
- CCM N/A
- KALA N/A
- 52 Week Low
- CCM $3.80
- KALA $2.92
- 52 Week High
- CCM $10.90
- KALA $11.20
- Technical
- Relative Strength Index (RSI)
- CCM 40.37
- KALA 61.92
- Support Level
- CCM $5.57
- KALA $4.36
- Resistance Level
- CCM $5.95
- KALA $5.75
- Average True Range (ATR)
- CCM 0.23
- KALA 0.53
- MACD
- CCM 0.00
- KALA 0.07
- Stochastic Oscillator
- CCM 48.19
- KALA 64.39
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.